HYPMY
Price
$4.47
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
2.79B
JUSHF
Price
$0.75
Change
-$0.00 (-0.00%)
Updated
Aug 28 closing price
Capitalization
145.02M
81 days until earnings call
Interact to see
Advertisement

HYPMY vs JUSHF

Header iconHYPMY vs JUSHF Comparison
Open Charts HYPMY vs JUSHFBanner chart's image
Hypera SA
Price$4.47
Change-$0.00 (-0.00%)
Volume$2.03K
Capitalization2.79B
Jushi Holdings
Price$0.75
Change-$0.00 (-0.00%)
Volume$1.32M
Capitalization145.02M
HYPMY vs JUSHF Comparison Chart in %
Loading...
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HYPMY vs. JUSHF commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HYPMY is a Hold and JUSHF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (HYPMY: $4.47 vs. JUSHF: $0.75)
Brand notoriety: HYPMY and JUSHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: HYPMY: 1% vs. JUSHF: 171%
Market capitalization -- HYPMY: $2.79B vs. JUSHF: $145.02M
HYPMY [@Pharmaceuticals: Generic] is valued at $2.79B. JUSHF’s [@Pharmaceuticals: Generic] market capitalization is $145.02M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $68.6B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HYPMY’s FA Score shows that 1 FA rating(s) are green whileJUSHF’s FA Score has 0 green FA rating(s).

  • HYPMY’s FA Score: 1 green, 4 red.
  • JUSHF’s FA Score: 0 green, 5 red.
According to our system of comparison, JUSHF is a better buy in the long-term than HYPMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HYPMY’s TA Score shows that 4 TA indicator(s) are bullish while JUSHF’s TA Score has 5 bullish TA indicator(s).

  • HYPMY’s TA Score: 4 bullish, 5 bearish.
  • JUSHF’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, JUSHF is a better buy in the short-term than HYPMY.

Price Growth

HYPMY (@Pharmaceuticals: Generic) experienced а +5.18% price change this week, while JUSHF (@Pharmaceuticals: Generic) price change was +12.68% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.25%. For the same industry, the average monthly price growth was +68.20%, and the average quarterly price growth was +81.63%.

Reported Earning Dates

JUSHF is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.25% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HYPMY($2.79B) has a higher market cap than JUSHF($145M). JUSHF YTD gains are higher at: 140.547 vs. HYPMY (52.165). HYPMY has higher annual earnings (EBITDA): 1.41B vs. JUSHF (44.8M). HYPMY has more cash in the bank: 1.2B vs. JUSHF (23.2M). JUSHF has less debt than HYPMY: JUSHF (269M) vs HYPMY (8.86B). HYPMY has higher revenues than JUSHF: HYPMY (6.66B) vs JUSHF (256M).
HYPMYJUSHFHYPMY / JUSHF
Capitalization2.79B145M1,924%
EBITDA1.41B44.8M3,152%
Gain YTD52.165140.54737%
P/E Ratio20.77N/A-
Revenue6.66B256M2,602%
Total Cash1.2B23.2M5,190%
Total Debt8.86B269M3,294%
FUNDAMENTALS RATINGS
HYPMY vs JUSHF: Fundamental Ratings
HYPMY
JUSHF
OUTLOOK RATING
1..100
319
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
49
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5235
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HYPMY's Valuation (9) in the null industry is somewhat better than the same rating for JUSHF (49). This means that HYPMY’s stock grew somewhat faster than JUSHF’s over the last 12 months.

HYPMY's Profit vs Risk Rating (100) in the null industry is in the same range as JUSHF (100). This means that HYPMY’s stock grew similarly to JUSHF’s over the last 12 months.

HYPMY's SMR Rating (100) in the null industry is in the same range as JUSHF (100). This means that HYPMY’s stock grew similarly to JUSHF’s over the last 12 months.

JUSHF's Price Growth Rating (35) in the null industry is in the same range as HYPMY (52). This means that JUSHF’s stock grew similarly to HYPMY’s over the last 12 months.

JUSHF's P/E Growth Rating (100) in the null industry is in the same range as HYPMY (100). This means that JUSHF’s stock grew similarly to HYPMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HYPMYJUSHF
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
66%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 18 days ago
70%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
HYPMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JUSHF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TLVCX16.58N/A
N/A
Timothy Plan Large/Mid Cap Value C
IRLUX46.04N/A
N/A
Voya Russell Large Cap Index Port S2
SQCBX13.86N/A
N/A
X-Square Balanced Fund, LLC C
NDVIX18.33N/A
N/A
MFS New Discovery Value I
OAKMX166.56-0.01
-0.01%
Oakmark Investor

HYPMY and

Correlation & Price change

A.I.dvisor tells us that HYPMY and PLNH have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HYPMY and PLNH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HYPMY
1D Price
Change %
HYPMY100%
N/A
PLNH - HYPMY
21%
Poorly correlated
-2.41%
CPIX - HYPMY
20%
Poorly correlated
+2.06%
GLASF - HYPMY
20%
Poorly correlated
+1.08%
KMDA - HYPMY
20%
Poorly correlated
-1.54%
JUSHF - HYPMY
18%
Poorly correlated
+0.11%
More

JUSHF and

Correlation & Price change

A.I.dvisor indicates that over the last year, JUSHF has been closely correlated with TCNNF. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if JUSHF jumps, then TCNNF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JUSHF
1D Price
Change %
JUSHF100%
+0.11%
TCNNF - JUSHF
74%
Closely correlated
+0.89%
CRLBF - JUSHF
74%
Closely correlated
+4.01%
CURLF - JUSHF
72%
Closely correlated
+5.20%
TSNDF - JUSHF
71%
Closely correlated
+0.89%
GTBIF - JUSHF
70%
Closely correlated
-0.59%
More